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Summary 
Neither excitotoxic neurodegeneration nor lipopolysaccharide induces an acute myelomonocytic 
exudate in the murine central nervous system (CNS) parenchyma (Andersson, P.-B., V. H. Perry, 
and S. Gordon.  1991. Neuroscience. 42:201; Andersson, P.-B., V. H. Perry, and S. Gordon.  1992. 
Neuroscience. 48:169). In this study formyl-methionyl-leucyl-phenylalanine, platelet-activating  factor, 
interleukin 8 (Ib8), IL-1, or tumor necrosis factor ot were injected into the hippocampus to assess 
whether these leukocyte chemotaxins  and known mediators  of recruitment  could bypass this 
block. They induced morphologic activation of microglia and widespread leukocyte margination 
but little or no ceU exudation into the CNS parenchyma.  By contrast,  there was acute myelo- 
monocytic cell recruitment to the choroid plexus, meninges, and ventricular system, comparable 
to that  in the  skin after subcutaneous injection.  The normal  CNS parenchyma  appears to be 
a tissue unique in its resistance to leukocyte diapedesis, which is shown here to be at a step beyond 
chemotactic cytokine secretion or induction  of leukocyte adhesion  to cerebral endothelium. 
O 
ur earlier studies have drawn attention to the fact that 
leukocyte responses after acute injury  to  the central 
nervous system (CNS) parenchyma (i.e.,  the grey and white 
matter) are not typical of that found in the other body tissues 
where rapid recruitment  of neutrophils and monocytes is a 
consistent phenomenon (1-6).  The myelomonocytic leuko- 
cyte infiltrate  found in  the degenerating  distal  segment  of 
the optic nerve after a crush injury is less than  that  found 
in sciatic  nerve (7). Since Wallerian degeneration is slower 
in CNS axons (8), crush injury in the optic nerve may pro- 
vide a weak proinflammatory  stimulus  and thus could ac- 
count for the difference in leukocyte responses. To test this, 
we induced rapid synchronous neuronal degeneration in the 
hippocampus  with  the  excitotoxin  kainic  acid.  Notwith- 
standing  extensive acute neuronal  necrosis and breakdown 
of the blood-brain barrier,  there was no neutrophil recruit- 
ment and a 2-d delay before macrophage-microglial numbers 
increased in the CNS parenchyma (9). Kainic acid itself did 
not induce acute inflammation in non-CNS tissue, and thus 
in order to compare leukocyte responses in CNS parenchyma 
with  that  in  other  organs,  we  injected  the  potent 
proinflammogen LPS directly into the hippocampus. The in- 
jection of 20 ng failed to induce any leukocyte recruitment, 
and doses up to 2 #g induced only minimal acute neutrophil 
exudation and a 2-d delay before a phase of monocyte-restricted 
recruitment commenced (10).  Taken together,  these experi- 
merits indicate that the CNS parenchyrna  is able to profoundly 
modify the leukocyte responses to acute injury. 
LPS is not directly chemotactic for leukocytes but it in- 
itiates myelomonocytic cell recruitment via resident tissue cells 
that  release  IL-1, TNF-oe,  and leukocyte chemotaxins  like 
platelet-activating factor (PAF) and II,-8. The purpose of the 
present experiments was to determine whether the resistance 
of normal CNS parenchyma to recruitment of leukocytes could 
be overcome by direct injection of these known final medi- 
ators. We find that they induce microglial activation and leu- 
kocyte margination but not emigration into CNS parenchyma. 
Materials  and Methods 
Reagents.  FMLP and PAF were obtained from Sigma Chem- 
ical Co. (Dorset, England). Human r/IL-lcr and 3 were obtained 
from Genzyme (Surrey, England). Murine r/TNF-cr  was a gift of 
Dr. S. Gillis (Immunex Corp., San Francisco, CA). Human r/IL-8 
was a gift of Dr.  I. Lindley (Sandoz Forschunginstitut,  Vienna, 
Austria).  Agents were LPS free by Limulus  lysate assay. 
Animals and Surgery.  Adult BALB/c mice of either  sex were 
obtained from the Sir William Dunn School (Oxford University), 
and C3H/HeJ mice were obtained from Harlan-Olac (Bicester, En- 
gland). Stereotactic injections of I ~1 were delivered into the dorsal 
hippocampus through a pulled glass micropipette of total external 
diameter 0.15-0.2  mm, as described previously (9,  10). 1 #1 was 
also injected into the skin of the ear using the same injection can- 
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a 1% solution ofmonastral blue (Sigma  Chemical Co.), which served 
as an inert tracer to locate the injection site and confirm delivery 
of the agent. Control injections were of 1% monastral blue-PBS 
or PBS alone. 
Tissue Processing  and Staining.  Animals  were deeply anesthetized 
and perfused with paraformaldehyde-lysine-periodate  fixative after 
saline perfusion 4 h, 12 h, 1 d, 2 d, 5 d, and 7 d after injection 
as described (9, 10). lO-/~m  frozen sections and indirect immuno- 
histoehemistry with a polyclonal  rabbit F4/80 antiserum were per- 
formed as described, and sections counterstained with cresyt violet 
to reveal  nuclear morphology (9, 10). The presence of neutrophils 
was detected by their characteristic multilobed nuclei, and macro- 
phages and microglia by F4/80 immunocytochemistry. F4/80 is 
a plasma membrane antigen of unknown function that is specific 
for macrophages and microglia in the CNS (11, 12), and no staining 
was detected in the absence of first antibody. Independent experi- 
ments were performed with at least two animals per time point. 
Results 
113l and TNE  The intrahippocampal injection of 0.5 U 
IDlc~ with 1 U IL-I~ produced no leukocyte recruitment to 
the CNS parenchyma despite the substantial  IL-1 receptor dis- 
tribution on neurons (13) (data not shown). We therefore 
injected large doses (up to 50 U IDI~ with 100 U  ID13 or 
104 U TNF-o  0. To our surprise there was trivial neutrophil 
exudation into the CNS parenchyma: rather than any my- 
elomonocytic infiltrate as observed when injections were made 
into the skin (Fig.  I a), only occasional isolated neutrophils 
were found (Fig.  1, d-g). At the high doses,  the paucity of 
recruitment was the more conspicuous for the striking mar- 
gination of neutrophils to blood vessels over a wide area up 
to a few millimeters from the injection site, indicating that 
the cytokines had diffused within the parenchyma (Fig.  1 g). 
Margination was evident from 4 to 24 h and maximal at 12 h 
after injection. The amount of margination observed for IL-1 
was much greater than that after TNF, and most likely reflects 
the larger proinflammatory dose of IL-1 used. There was also 
no significant recruitment of monocytes into the parenchyma 
after IL-1 or TNF injection. Apart from the limited reaction 
in the cannula track similar to that with control vehicle in- 
jections and described previously (10), the normal regular dis- 
tribution of F4/80 + cells (microglia) in the neurophil was 
unchanged by the cytokine injections (Fig.  1, d and e) and 
there was no increase in their number (data not shown). How- 
ever, instead of normal uniform F4/80 staining intensity (14), 
microglia in the injected hippocampus and overlying cortex 
displayed increased staining intensity from 12 to 24 h com- 
pared with microglia elsewhere in the section. Some microglia 
within a few hundred microns of the injection site displayed 
shortened cell processes and increased arborization over the 
first 24-48 h of the time course (Fig.  1 j~. Thus, ID1 and 
TNF-a had effects on both microglia (morphologic activa- 
tion) and on cerebral endothelium (neutrophil margination), 
but minimal leukocyte recruiting action. 
While there was minimal leukocyte recruitment into CNS 
parenchyma, the intrahippocampal injections of II.-1 or TNF-c,, 
even at low doses,  induced a typical acute myelomonocytic 
inflammatory response in the ventricular system that is ana- 
tomically distant from the site of delivery and beyond the 
region of parenchymal microglial activation or leukocyte mar- 
gination.  This  distant  activity presumably resulted  from 
diffusion through extracellular CSF to the choroid plexus. 
Numerous  leukocytes were present  in  the ventricles  and 
subarachnoid space from 4 to 24 h, and also in choroid plexus 
stroma at 4 h (Fig.  1, b and c). By 12 h the choroid plexus 
was normal, but leukocytes were still present in the ventricles 
and subarachnoid space, especially in recesses of the third ven- 
tricle ipsilateral  to the injected hemisphere. By 48 h leuko- 
cytes were no longer present in the ventricles. In control ex- 
periments, there were no leukocytes in the subarachnoid space, 
ventricles, or choroid plexus when vehicle (PBS or PBS/monas- 
tral blue) was injected alone, and the tracer had no effect on 
the responses to cytokine injections. Similar leukocyte responses 
were also found in cytokine-injected C3H/HeJ mice, indi- 
cating that they were not caused by LPS contamination. 
FMLP,  PAF, and Ib8.  IL-1 and TNF  are not  directly 
chemotactic for leukocytes in vitro (15) and their leukocyte 
recruiting effects are mediated by resident tissue cells. The 
next series of experiments tested whether a potent leukocyte 
chemotaxin placed in the CNS parenchyma would be able 
to induce leukocyte emigration into the tissue,  as predicted 
by its actions in vitro. 
Subcutaneous injections into the ear of FMLP (10-1,000 
pmol), PAF (1-10 nmol), or IL-8 (10-1000 rig) with monas- 
tral blue tracer induced extensive neutrophil infiltration at 
4 h (data not shown). After intrahippocampal injection, there 
was a neutrophil inflammatory response in the ventricutar 
system, choroid plexus, and meninges, as seen for IL-1 and 
TNF (Fig. 2 a). However, at the actual injection site in hip- 
pocampus there were very few neutrophils and not substan- 
tially more than the response to vehicle alone, despite the 
delivery of large doses of agent (Fig. 2, b-e). The intracerebral 
injection of the largest dose of IL-8 tested (1 #g) was excep- 
tional in that it produced neutrophil exudation into the pa- 
renchyma but it was within the vicinity of the injection track, 
although dense neutrophil margination was observed in vessels 
up  to  several millimiters away (Fig.  2,  b and c).  All  the 
chemotaxins induced neutrophil margination and morpho- 
logic microglial activation in the injected hippocampus and 
overlying cerebral cortex from 12 h  after injection; F4/80 
staining intensity increased compared with that present in 
other regions of the tissue section, and many cells in this 
region displayed shortened processes for the next 2 d. Thus, 
a range of chemotaxins having diverse chemical structures 
similarly failed to induce significant leukocyte recruitment 
to the CNS parenchyma. 
Discussion 
Four striking findings were made in the present experi- 
ments. First,  the single bolus delivery of proinflammatory 
cytokine ID1 or TNF, or the leukocyte chemotaxin FMLP, 
PAF, or Ib8 into the normal adult hippocampus, failed to 
induce significant myelomonocytic  recruitment to the paren- 
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F4/80-stained sections  to show leu- 
kocyte  responses  to  intrahip- 
pocampal  injection  of  IL-1 or TNF-o~ 
at 12 h. Subcutaneous  injection of 
50 U II~1~ with 100 U IblB in the 
ear induces  a large myelomonocytic 
infiltrate on both sides of the carti- 
lage at this time (a). When injected 
into the hippocampus there is a my- 
elomonocytic infiltrate in the sub- 
arachnoid space  (arrowheads) (b), and 
choroid plexus (at 4 h) (c), but not 
at the site of  injection (d) (tracer  in- 
dicated  by arrow). High-power  views 
of the parenchymal response show 
that Ibl-induced morphological  ac- 
tivation of microglia  (arrowhead) (f), 
and leukocyte  margination (arrows) 
(g) but minimal diapedesis. Injec- 
tions  of  104  U  TNFc~ induced 
similar leukocyte and  microglial 
reactions (e) (bars, 50 #m: a,b,c,f, 
and g; and 0.5 ram: d and e). 
chyma as  they do in  other  tissues.  Of note in this  regard, 
chronic TNF release by intracerebral TNF-secreting tumors 
also does not induce inflammation in the CNS parenchyma 
(16). Thus, the highly modified leukocyte responses in CNS 
parenchyma during neuronal degeneration or after LPS in- 
jection (9, 10) are also observed with several different medi- 
ators of leukocyte recruitment, and therefore even if they are 
produced in these lesions,  would be expected to have min- 
imal  acute recruiting  activity. 
Second, since leukocyte chemotaxins failed to induce recruit- 
ment into parenchyma, it indicates that a chemotaxin in vitro 
is not necessarily one in vivo and that their leukocyte recruiting 
ability  is  not  mediated  solely  through  the  creation  of  a 
chemotactic gradient across a blood vessel. Evidence for this 
already  exists  in  nonneural  tissues  (the  tachyphylaxis 
phenomenon)  in which repeated intradermal  injection of a 
chemotaxin induces local desensitization of leukocyte recruit- 
ment  to  that  specific agent  (17). 
Third, margination could be separated from diapedesis in 
CNS parenchyma indicating that they are distinct events and 
that inhibition of leukocyte recruitment lies at the latter step. 
It must be remembered that margination and microglial ac- 
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physiological ones had negligible effect in the parenchyma. 
Finally, the intrahippocampal injection of all the proinflam- 
matory mediators induced rapid myelomonocytic  cell recruit- 
ment to the choroid plexus and ventricular system, as they 
do when injected into other tissues.  These findings are in 
agreement with those of previous workers who showed Ibl 
and TNF delivered intracisternaUy induced rapid myelomono- 
cytic recruitment to the CSF (5, 6). However, our findings 
here and previously (10) show that leukocyte inflammatory 
responses in the choroid plexus-CSF compartment are inde- 
pendent of those in the CNS parenchyma and from which 
they must be distinguished. We do not know whether the 
Figure 2.  Different  leukocyte  re- 
sponses at  12 h after intrahippo- 
campal injection of chemotaxins. 
The injection  of 1/~g IL-8 induces 
abundant neutrophil  infiltration  of 
the subarachnoid  space (a), but in 
parenchyma  it is confined  to the re- 
gion of the cannula track (arrows) 
and is minor  (b and c) though there 
is dense margination  visible  in the 
large vessels at this magnification 
(arrowheads)  (b). The injection  of 100 
pmol FMLP with tracer also fails 
to induce a myelomonocytic  infil- 
trate in the parenchyma  (d and e) 
(bars, 50/zm: a,b,c, and e; and 0.5 
mm: d). 
inhibition of leukocyte recruitment is due to the cerebral en- 
dothelium, which has a different morphologic structure (18), 
antigen phenotype (19, 20), and response to cytokine stimu- 
lation in vitro (21) compared with endothelium elsewhere; 
to the microglia, which are immunologically  downregulated 
compared with macrophages in the choroid plexus, ventricles, 
meninges, or elsewhere in the body (22); or to a cell-associated 
or extracellular matrix component of parenchyma that in- 
hibits leukocyte entry. The precise mechanisms are of con- 
siderable interest not only in understanding the pathogenesis 
of CNS disease, but also for possible antiinflammatory  appli- 
cation in other tissues. 
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